ADC Therapeutics Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ADC Therapeutics Ltd
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
/ 
Frequently asked questions
To buy ADC Therapeutics Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ADC Therapeutics Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ADC Therapeutics Ltd is ADCT:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ADC Therapeutics Ltd has its primary listing on New York Stock Exchange. You can trade ADC Therapeutics Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ADC Therapeutics Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ADC Therapeutics Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ADC Therapeutics Ltd.